Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CREBBP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CREBBP is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, regulates. Associated with Als, Amyotrophic Lateral Sclerosis, Cancer. Connected to 321 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | CREBBP |
| Full Name | CREB Binding Protein |
| Chromosome | 16p13.3 |
| Protein Type | Transcription Factor |
| Function | is a transcriptional coactivator that acetylates histones and transcription factors |
| Primary Expression | most neuronal subtypes including pyramidal cells, interneurons - Glia: Present in astrocytes and [microglia](/entities/mic |
| Molecular Weight | 265 kDa |
| Pathways | NF-κB |
| UniProt ID | Q92793 (CREBBP) |
| NCBI Gene ID | 1387 |
| Ensembl ID | ENSG00000105383 |
| OMIM | 600140 |
| GeneCards | CREBBP |
| Human Protein Atlas | CREBBP |
| Associated Diseases | ALS, Cancer, Parkinson, Tumor |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACAT1, AMPK, APOPTOSIS, ATG, BCL2, CALCOCO2 |
| SciDEX Hypotheses | Synaptic Chromatin Compartment Rejuvenation |
| KG Connections | 485 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CREBBP["CREBBP"] -->|"Regulates"| histone_H2B_acetylation["histone H2B acetylation"]
CREBBP["CREBBP"] -->|"Associated With"| Tumor["Tumor"]
CREBBP["CREBBP"] -->|"Associated With"| Parkinson["Parkinson"]
CREBBP["CREBBP"] -->|"Therapeutic Target"| Cancer["Cancer"]
CREBBP["CREBBP"] -->|"Therapeutic Target"| Ms["Ms"]
CREBBP["CREBBP"] -->|"Therapeutic Target"| Glioblastoma["Glioblastoma"]
CREBBP["CREBBP"] -->|"Therapeutic Target"| Fibrosis["Fibrosis"]
CREBBP["CREBBP"] -->|"Therapeutic Target"| Hepatitis["Hepatitis"]
OPTN["OPTN"] -->|"Associated With"| CREBBP["CREBBP"]
ULK1["ULK1"] -->|"Associated With"| CREBBP["CREBBP"]
CALCOCO2["CALCOCO2"] -->|"Associated With"| CREBBP["CREBBP"]
HSPA8["HSPA8"] -->|"Associated With"| CREBBP["CREBBP"]
STX17["STX17"] -->|"Associated With"| CREBBP["CREBBP"]
style CREBBP fill:#8d4900,color:#e0e0e0
style histone_H2B_acetylation fill:#1b5e20,color:#e0e0e0
style Tumor fill:#b71c1c,color:#e0e0e0
style Parkinson fill:#b71c1c,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Glioblastoma fill:#b71c1c,color:#e0e0e0
style Fibrosis fill:#b71c1c,color:#e0e0e0
style Hepatitis fill:#b71c1c,color:#e0e0e0
style OPTN fill:#8d4900,color:#e0e0e0
style ULK1 fill:#8d4900,color:#e0e0e0
style CALCOCO2 fill:#8d4900,color:#e0e0e0
style HSPA8 fill:#8d4900,color:#e0e0e0
style STX17 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Reactive Oxygen Species | regulates | process | 0.85 |
| acetylation | promotes | process | 0.85 |
| Parkinson's Disease | regulates | disease | 0.80 |
| Cancer | therapeutic_target | disease | 0.75 |
| synaptic plasticity | regulates | phenotype | 0.70 |
| histone H2B acetylation | regulates | process | 0.70 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Lymphoma | interacts_with | disease | 0.65 |
| Colorectal Cancer | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Leukemia | inhibits | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Schizophrenia | activates | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| Pancreatic Cancer | therapeutic_target | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Glioblastoma | therapeutic_target | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Migraine | inhibits | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Carcinoma | interacts_with | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| ULK1 | co_discussed | gene | 0.60 |
| TP53 | co_discussed | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| TFEB | co_discussed | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BECN1 | regulates | gene | 0.65 |
| BRG1 | regulates | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| EP300 | regulates | gene | 0.60 |
| CTNNB1 | regulates | gene | 0.60 |
| NEUROD1 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| VEGFA | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| FOXM1 | regulates | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| FGF20 | therapeutic_target | gene | 0.60 |
| TERT | therapeutic_target | gene | 0.60 |
| FZD7 | therapeutic_target | gene | 0.60 |
| JAG1 | therapeutic_target | gene | 0.60 |
| MITF | therapeutic_target | gene | 0.60 |
| TRPA1 | inhibits | gene | 0.60 |
| SRC | inhibits | gene | 0.60 |
| SCN8A | regulates | gene | 0.60 |
| AKT1 | regulates | gene | 0.60 |
| TRPM3 | regulates | gene | 0.60 |
| PRKAA1 | regulates | gene | 0.60 |
| BECN1 | activates | entity | 0.60 |
| CALCOCO2 | activates | entity | 0.60 |
| SMARCA4 | regulates | gene | 0.60 |
| MAP1LC3 | associated_with | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| MOTOR NEURONS | regulates | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 0.60 |
| ALS | regulates | gene | 0.60 |
| MIRNAS | expressed_in | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| MICRORNAS | expressed_in | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| CREB | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| COL4A1 | interacts_with | gene | 0.60 |
| KAT8 | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| CALCOCO2 | associated_with | gene | 0.60 |
| HSPA8 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| RB1CC1 | associated_with | gene | 0.60 |
| SIRT1 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Synaptic Chromatin Compartment Rejuvenation | 0.000 | - | Epigenetic reprogramming in aging neuron |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 16 hypotheses Top: 0.779
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning CREBBP in their description or question text
No additional research found